Back to Authors

Kantoff, Philip W.

https://orcid.org/0000-0001-7275-0597

A5056766924 | I1334819555

Mayo Clinic

39Convergent Therapeutics, Cambridge, MA

Citations 13

Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) and survival in metastatic prostate cancer (PCa).

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 1540-1540

10.1200/jco.2016.34.15_suppl.1540

Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5044-5044

10.1200/jco.2018.36.15_suppl.5044

Symposium on Androgen Action in Prostate Cancer

Cancer Research | September 20, 2005 | Volume: 64 | Issue: 19 | Pages: 7178-7180

10.1158/0008-5472.can-04-1752 | PMID 15466216